All In Biotech

Drug Trial Radar · NCT00239642

Safety and Efficacy of Iron Sucrose in Children

Comparison of the Safety and Efficacy of Three Iron Sucrose Maintenance Regimens in Pediatric Chronic Kidney Disease (CKD) Patients

Last checked: Nov 20, 2026Latest source record: Nov 17, 2021 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registryPivotal-lookingRandomized with 141 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

141

Actual

Start

Jul 2005

Primary completion

Jan 2009

Study completion Apr 2010

Sponsor

Lead sponsor
American Regent, Inc.Industry
Sponsor type
Industry
First posted
Oct 17, 2005

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 4
Allocation
Randomized
Model
Parallel
Masking
None
Primary purpose
Treatment
Who can join
All sexes, from 2 years, up to 21 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

Comparison of three potential iron sucrose maintenance regimens in pediatric chronic kidney disease (CKD) patients

Conditions

  • Anemia
  • Chronic Kidney Disease

Interventions

  • Venofer (iron sucrose injection)Drug

    0.5 mg/kg of Venofer (iron sucrose) up to 100 mg administered intravenously

  • Venofer (iron sucrose injection)Drug

    1.0 mg/kg of Venofer (iron sucrose) up to 100 mg administered intravenously

  • Venofer (iron sucrose injection)Drug

    2.0 mg/kg of Venofer (iron sucrose) up to 100 mg administered intravenously

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Safety Profile: Number of Subjects Experiencing at Least 1 Adverse EventTime frame: baseline through week 12

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Luitpold Pharmaceutials

    Norristown, Pennsylvania

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.